Czechia, April 27 -- Czechia based Takeda Pharmaceuticals Czech Republic s.r.o. has secured contract from Fakultni nemocnice Plzen for Antineoplastic and immunomodulating agents - Antineoplastica and immunomodulators 2026. The value of the contract is worth 2729260512 CZK.
Published by HT Digital Content Services with permission from Pivotal Sources....